For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Levonorgestrel Arm | Only one study arm. All women were assigned to take 0.75 mg oral contraceptive pills (levonorgestrel) within 24 hours of engaging in sex. | None | None | 0 | 72 | 28 | 72 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| irritability | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| chlamydial infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| ear infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| rhinitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| sinusitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| tonsilitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| upper respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| urinary tract infections | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| vaginal candidiasis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dysuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| cervical dysplasia | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| decereased libido | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| vaginal discharge | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| dermititis allergic | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| seborrhea | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |